Twist Bioscience CorporationTWSTNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank22
3Y CAGR-38.7%
5Y CAGR-14.6%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
-38.7%/yr
vs -4.0%/yr prior
5Y CAGR
-14.6%/yr
Recent deceleration
Acceleration
-34.7pp
Decelerating
Percentile
P22
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 13.09% |
| 2024 | 15.11% |
| 2023 | -10.90% |
| 2022 | 56.69% |
| 2021 | 31.60% |
| 2020 | 28.88% |
| 2019 | 84.41% |
| 2018 | 66.73% |
| 2017 | 42.61% |
| 2016 | 0.00% |